Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vericel Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +12 vs. Q4 2021
- Shares held
- 52.6M
- +637.3K (+1.2%) vs. Q4 2021
- Total value
- $2.01B
- −$29.0M (−1.4%) vs. Q4 2021
- New holders
- 33
- 70 more added
- Sold out
- 21
- 71 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $2.47B |
| Q1 2026 | 280 | $1.78B |
| Q4 2025 | 274 | $1.93B |
| Q3 2025 | 249 | $1.67B |
| Q2 2025 | 273 | $2.35B |
| Q1 2025 | 277 | $2.39B |
| Q4 2024 | 278 | $2.87B |
| Q3 2024 | 268 | $2.15B |
| Q2 2024 | 261 | $2.32B |
| Q1 2024 | 257 | $2.68B |
| Q4 2023 | 227 | $1.84B |
| Q3 2023 | 214 | $1.73B |
| Q2 2023 | 202 | $1.88B |
| Q1 2023 | 200 | $1.48B |
| Q4 2022 | 178 | $1.32B |
| Q3 2022 | 180 | $1.21B |
| Q2 2022 | 183 | $1.34B |
| Q1 2022 | 197 | $2.01B |
| Q4 2021 | 185 | $2.04B |
| Q3 2021 | 202 | $2.48B |
| Q2 2021 | 205 | $2.57B |
| Q1 2021 | 205 | $2.75B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vericel Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Summit Global Investments | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −15,014−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −13,325−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −11,901−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −8,561−100.0% | Sold out |
| IndexIQ Advisors LLC | 0 | $0 | 0.00% | −7,602−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −6,962−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −5,556−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −5,499−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,200−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,517−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −4,324−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −4,314−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −2,240−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −419−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |